Unlock instant, AI-driven research and patent intelligence for your innovation.

Broad-spectrum carbapenems

A kind of alkenyl compound technology, applied in organic chemistry, pharmaceutical formulation, antibacterial drugs, etc., can solve problems such as inactivity and clinical failure

Pending Publication Date: 2021-03-16
VENATORX PHARMA INC
View PDF13 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Carbapenem β-lactams face two important issues with regard to their utility: (1) their resistance to MDR Gram-positive bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Staphylococcus aureus (VRSA)) was inactive, and (2) clinical failure due to the spread of β-lactamase-producing Gram-negative Enterobacteriaceae and Pseudomonas aeruginosa

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Broad-spectrum carbapenems
  • Broad-spectrum carbapenems
  • Broad-spectrum carbapenems

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0543] Compound preparation

[0544]Described herein are compounds, or pharmaceutically acceptable salts, solvates, or stereoisomers thereof, which are useful in the treatment of bacterial infections, and methods for their preparation. In some embodiments, a compound described herein, or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof, is synthesized using standard synthetic reactions known to those of skill in the art or using methods known in the art. These reactions can be used in a linear sequence to provide compounds, or they can be used to synthesize fragments that are subsequently ligated by methods known in the art. In some embodiments, starting materials used in the synthesis of compounds described herein are synthesized or obtained from sources such as, but not limited to, Aldrich Chemical Co. (Milwaukee, Wisconsin), Bachem (Torrance, California), or Sigma Chemical Co. (St. Louis, Mo.) from commercial sources. In some embodiments, the compounds...

Embodiment 1

[0582] Example 1: (4R,5S,6S)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-3-(((R)-1-(piperidine- 4-yl)pyrrolidin-3-yl)thio)-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid.

[0583]

[0584] Step 1: Synthesis of (S)-tert-butyl 3-((methylsulfonyl)oxy)pyrrolidine-1-carboxylate.

[0585]

[0586] To a solution of (S)-Boc-3-pyrrolidinol (8.42 g, 45 mmol) in DCM (150 mL) at 0 °C was added triethylamine (9.5 mL, 68.2 mmol) followed by methanesulfonyl chloride (4 mL, 50.8 mmol). The reaction mixture was stirred at 0 °C for 30 min, then warmed to room temperature for 30 min, and washed with saturated NaHCO 3 Washed with aqueous solution, Na 2 SO 4 Drying and concentration in vacuo gave the crude product which was used in the next step without further purification.

[0587] Step 2: Synthesis of (R)-tert-butyl 3-(acetylthio)pyrrolidine-1-carboxylate.

[0588]

[0589] To a solution of the crude formate in acetone (380 mL) was added potassium thioacetate (7.8 g, 68.3 mmol). The ...

Embodiment 2

[0608] Example 2: (4R,5S,6S)-6-((R)-1-hydroxyethyl)-4-methyl-7-oxo-3-(((S)-1-(piperidine- 4-yl)pyrrolidin-3-yl)thio)-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid.

[0609]

[0610] Except using (R)-Boc-3-pyrrolidinol instead of (S)-Boc-3-pyrrolidinol as the starting material in step 1, the target compound was prepared according to the same reaction procedure as described in Example 1 . ESI-MS m / z 396(MH) + .

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The present disclosure provides broad-spectrum carbapenem derivatives and pharmaceutical compositions useful in the treatment of bacterial infections and methods for treating such infections using such derivatives and / or compositions.

Description

[0001] cross reference [0002] This application claims the benefit of U.S. Provisional Application Serial No. 62 / 678,151, filed May 30, 2018, which is hereby incorporated by reference in its entirety. [0003] Statement Regarding Federally Funded Research [0004] This invention was made with US government support under SBIR grant R43AI120392 awarded by the National Institutes of Health (NIH) and SBIR grant R44AI120392 awarded by the National Institutes of Health (NIH). The US Government has certain rights in this invention. Background technique [0005] Antibiotics are the most effective drugs clinically used to treat bacterial-associated infectious diseases. They are very valuable treatment options, but are currently losing efficacy due to the evolution and spread of resistance genes. Dramatic increases in infection rates by multidrug resistant (MDR) Gram-positive and Gram-negative organisms are now occurring both in hospitals and in the community. Carbapenem β-lacta...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D477/20A61P31/04
CPCC07D477/20A61P31/04A61K31/407A61K45/06
Inventor 克里斯多佛·J·伯恩斯楚国华朱迪·哈姆里克史蒂文·A·博伊德斯蒂芬·M·康登
Owner VENATORX PHARMA INC